GLP-1 receptor agonists
GLP-1 medications are not approved for type 1 diabetes. Clients with prior pancreatitis or MTC/MEN2 should not use these medications.
- Nausea, vomiting, diarrhea, constipation (very common; dose-related)
- Decreased appetite (intended effect; also a side effect)
- Headache, fatigue (early weeks)
- Injection-site reactions
- Pancreatitis (severe abdominal pain → stop the medication and seek emergency care)
- Gallbladder disease (rapid weight loss can precipitate gallstones)
- Thyroid C-cell tumors (boxed warning; contraindicated with personal/family history)
- Hypoglycemia if combined with insulin or sulfonylureas
- Acute kidney injury (from dehydration from severe GI symptoms)